06 agosto 2020
Goldman Sachs says investors are underestimating the chance of a COVID-19 vaccine in 2020
Goldman Sachs says investors are underestimating the chance of a COVID-19 vaccine in 2020, an event that could push the S&P 500 11% higher: "We agree that there is now a good chance that at least one vaccine will be FDA-approved by the end of November and broadly distributed by the middle of 2021," they added.
-
StayAway Covid: após 38 mil casos, foram gerados apenas 730 códigos de infectados : Entre dois milhões de downloads e mais de 38 mil doe...
-
The Tricky Math of COVID-19 Herd Immunity : Herd immunity differs from place to place, and many factors influence how it’s calculated.
-
The Coronavirus Pandemic Isn’t Over—We Need to Act Accordingly : You might be tired of living this way. But the virus doesn’t care.